Follow the people · Insider
David Baxley Spetzler
David Baxley Spetzler files insider transactions with the SEC as a president of Caris Life Sciences (CAI). We hold 2 disclosed purchases and sales filed since 23 June 2025, 2 of them in the last 90 days.
- Files forCAI
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure4 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 3 March 2025 — 4 September 2026President · Caris Life Sciences (CAI)18 Form 4 lines · source: SEC Form 4
Everything they disclosed
18 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 1,000,000 shares of Caris Life SciencesSEC Form 44 September 2026Common Stock · traded 3 September 2026 · filed 4 September 2026
- ▼ sold on the open market 393,100 shares of Caris Life SciencesSEC Form 44 September 2026Common Stock · traded 3 September 2026 · filed 4 September 2026
- ▼ sold on the open market 84,900 shares of Caris Life SciencesSEC Form 44 September 2026Common Stock · traded 3 September 2026 · filed 4 September 2026
- exercised options over 250,000 shares of Caris Life SciencesSEC Form 44 September 2026Common Stock · traded 4 September 2026 · filed 4 September 2026
- ▼ sold on the open market 119,212 shares of Caris Life SciencesSEC Form 44 September 2026Common Stock · traded 4 September 2026 · filed 4 September 2026
- exercised options over 1,000,000 shares of Caris Life Sciences (a derivative holding)SEC Form 44 September 2026Stock Option · traded 3 September 2026 · filed 4 September 2026
- exercised options over 250,000 shares of Caris Life Sciences (a derivative holding)SEC Form 44 September 2026Stock Option · traded 4 September 2026 · filed 4 September 2026
- had shares withheld for tax on 13,856 shares of Caris Life SciencesSEC Form 418 May 2026Common Stock · traded 15 May 2026 · filed 18 May 2026
- was granted 83,162 shares of Caris Life SciencesSEC Form 410 March 2026Common Stock · traded 6 March 2026 · filed 10 March 2026
- was granted 83,162 shares of Caris Life SciencesSEC Form 410 March 2026Common Stock · traded 6 March 2026 · filed 10 March 2026
- ▲ bought on the open market 400 shares of Caris Life SciencesSEC Form 410 November 2025Common Stock · traded 7 November 2025 · filed 10 November 2025
- had shares withheld for tax on 63,509 shares of Caris Life SciencesSEC Form 413 August 2025Common Stock · traded 11 August 2025 · filed 13 August 2025
- was granted 750,000 shares of Caris Life Sciences (a derivative holding)SEC Form 423 June 2025Stock Option · traded 3 March 2025 · filed 23 June 2025
- exercised options over 75,000 shares of Caris Life Sciences (a derivative holding)SEC Form 423 June 2025Stock Option · traded 20 June 2025 · filed 23 June 2025
- returned to the issuer 700,509 shares of Caris Life SciencesSEC Form 423 June 2025Common Stock · traded 3 March 2025 · filed 23 June 2025
- was granted 132,428 shares of Caris Life SciencesSEC Form 423 June 2025Common Stock · traded 18 June 2025 · filed 23 June 2025
- exercised options over 75,000 shares of Caris Life SciencesSEC Form 423 June 2025Common Stock · traded 20 June 2025 · filed 23 June 2025
- had shares withheld for tax on 34,782 shares of Caris Life SciencesSEC Form 423 June 2025Common Stock · traded 20 June 2025 · filed 23 June 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.